Public filings / UTHR on Yahoo Finance (opens in a new tab)
UTHR: insider buying, 13F holders, analyst moves
United Therapeutics Corp - US
A summary of public filings about United Therapeutics Corp - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold UTHR
Combined reported value $1.83B.
Holders among our 100 managers: 1 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors | $1.51B | 13.51% | Added |
| Deerfield Company | $247.6M | 2.58% | Unchanged |
| Deep Track Capital | $67.0M | 0.99% | New |
| Tudor Investment | $6.9M | 0.03% | New |
| Rokos Capital | $5.8M | 0.07% | New |
SEC Form 4
Recent insider trades in UTHR
| Filed (ET) | Insider | Type | Value | Filing |
|---|---|---|---|---|
| 2026-10-15 16:34 | ROTHBLATT MARTINE A Chairperson & CEO | Sale | $5.1M | SEC |
As of the last site build. The live lookup shows 12 months of Form 4 filings.
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.